Cited by 554Hepatitis B Virus StudiesHepatitis C virus researchLiver physiology and pathology

The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.

Control of cccDNA function in hepatitis B virus infection

Open access

Levrero, Massimo, Pollicino, Teresa, Petersen, Jorg, Belloni, Laura, Raimondo, Giovanni, Dandri, Maura·2009·Journal of Hepatology

DOI 10.1016/j.jhep.2009.05.022

Open this paper in CoChat — free account Open PDF

Abstract

The template of hepatitis B virus (HBV) transcription, the covalently closed circular DNA (cccDNA), plays a key role in the life cycle of the virus and permits the persistence of infection. Novel molecular techniques have opened new possibilities to investigate the organization and the activity of the cccDNA minichromosome in vivo, and recent advances have started to shed light on the complexity of the mechanisms controlling cccDNA function. Nuclear cccDNA accumulates in hepatocyte nuclei as a stable minichromosome organized by histone and non-histone viral and cellular proteins. Identification of the molecular mechanisms regulating cccDNA stability and its transcriptional activity at the RNA, DNA and epigenetic levels in the course of chronic hepatitis B (CH-B) infection may reveal new potential therapeutic targets for anti-HBV drugs and hence assist in the design of strategies aimed at silencing and eventually depleting the cccDNA reservoir.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2009.05.022

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Acetylation of Histones and Transcription-Related Factors
Sterner, D. E., & Berger, S. L. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.2.435-459.2000 · Cited by 1,824
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
Guidotti, L. G., Rochford, R., Chung, J., Shapiro, M., Purcell, R., & Chisari, F. V. (1999) · Science · doi:10.1126/science.284.5415.825 · Cited by 1,223
Hepatitis B Virus Infection: Epidemiology and Vaccination
Shepard, C. W. (2006) · Epidemiologic Reviews · doi:10.1093/epirev/mxj009 · Cited by 1,152
Cellular Memory and the Histone Code
Turner, B. M. (2002) · Cell · doi:10.1016/s0092-8674(02)01080-2 · Cited by 1,142
Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection
Boni, C., Fisicaro, P., Valdatta, C., Amadei, B., Di Vincenzo, P., Giuberti, T., Laccabue, D., Zerbini, A., Cavalli, A., Missale, G., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02844-06 · Cited by 920
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆
Werle–Lapostolle, B., Bowden, S., Locarnini, S., Wursthorn, K., Petersen, J., Lau, G., Trepo, C., Marcellin, P., Goodman, Z., & Delaney IV, W. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.018 · Cited by 905
The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response
Rehermann, B., Ferrari, C. I., Pasquinelli, C., & Chisari, F. V. (1996) · Nature Medicine · doi:10.1038/nm1096-1104 · Cited by 850
Statements from the Taormina expert meeting on occult hepatitis B virus infection
Raimondo, G., Allain, J., Brunetto, M. R., Buendia, M., Chen, D., Colombo, M. G., Craxı̀, A., Donato, F., Ferrari, C. I., Gaeta, G. B., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.014 · Cited by 828
Mechanisms of Liver Injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways
Schwabe, R. F., & Brenner, D. A. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00422.2005 · Cited by 684

Show all 90 references

Research works printed but not linked: 1

Koepke, 2008, Genetic variability of the cccDNA regulatory region changes significantly in the different phases of chronic HBV infection, Hepatology, 48, 683A

Sorted by citations

Items 201–300 of 554

HBx represses WDR77 to enhance HBV replication by DDB1-mediated WDR77 degradation in the liver
Yuan, H., Zhao, L., Yuan, Y., Yun, H., Zheng, W., Geng, Y., Yang, G., Wang, Y., Zhao, M., & Zhang, X. (2021) · Theranostics · doi:10.7150/thno.57531 · Cited by 32
siRNA drug development against hepatitis B virus infection
Flisiak, R., Jaroszewicz, J., & Łucejko, M. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1472231 · Cited by 32
High mobility group AT-hook 1 (HMGA1) is an important positive regulator of hepatitis B virus (HBV) that is reciprocally upregulated by HBV X protein
Shen, Z., Wu, J., Gao, Z., Zhang, S., Chen, J., He, J., Guo, Y., Deng, Q., Xie, Y., Liu, J., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac070 · Cited by 31
Deregulation of Epigenetic Mechanisms by the Hepatitis B Virus X Protein in Hepatocarcinogenesis
ANDRISANI, O. M. (2013) · Viruses · doi:10.3390/v5030858 · Cited by 31
Dynamics of HBV cccDNA expression and transcription in different cell growth phase
Chong, C.-L., Chen, M.-L., Wu, Y.-C., Tsai, K.-N., Huang, C.-C., Hu, C., Jeng, K.-S., Chou, Y., & Chang, C. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-96 · Cited by 30
IFN-α inhibits HBV transcription and replication by promoting HDAC3-mediated de-2-hydroxyisobutyrylation of histone H4K8 on HBV cccDNA minichromosome in liver
Zhao, L., Yuan, H., Wang, Y., Yun, H., Zheng, W., Yuan, Y., Geng, Y., Zhao, M., Feng, L.-Y., & Zhang, X. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00765-7 · Cited by 32
Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma
Zhang, Y., Cao, W., Wang, S., Zhang, L., Li, X., Zhang, Z., Xie, Y., & Li, M. (2024) · Virulence · doi:10.1080/21505594.2024.2421231 · Cited by 32
Mutual antagonism between hepatitis B viral mRNA and host microRNA let-7
Takata, A., Otsuka, M., Ohno, M., Kishikawa, T., Yoshikawa, T., & Koike, K. (2016) · Scientific Reports · doi:10.1038/srep23237 · Cited by 29
Hepatitis B virus: from immunobiology to immunotherapy
Grimm, D. G., Heeg, M., & Thimme, R. (2012) · Clinical Science · doi:10.1042/cs20120169 · Cited by 28
Oligonucleotide-Based Therapies for Chronic HBV Infection: A Primer on Biochemistry, Mechanisms and Antiviral Effects
Vaillant, A. (2022) · Viruses · doi:10.3390/v14092052 · Cited by 30
Recent insights into hepatitis B virus–host interactions
Ezzikouri, S., Ozawa, M., Kohara, M., Elmdaghri, N., Benjelloun, S., & Tsukiyama–Kohara, K. (2014) · Journal of Medical Virology · doi:10.1002/jmv.23916 · Cited by 28
Requirement of CRTC1 coactivator for hepatitis B virus transcription
Tang, H.-M. V., Gao, W., Chan, C., Cheng, Y., Chaudhary, V., Deng, J.-J., Yuen, K., Wong, C., Ng, I. O., Kok, K., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku925 · Cited by 28
Elimination of the hepatitis B virus: A goal, a challenge
Pondé, R. A. D. A., & Amorim, G. D. S. P. (2024) · Medicinal Research Reviews · doi:10.1002/med.22030 · Cited by 28
Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma
Luo, X., Huang, Y., Chen, Y., Tu, Z., Hu, J., Tavis, J. E., Huang, A., & Hu, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157708 · Cited by 27
Novel viral and host targets to cure hepatitis B
Ko, C., Michler, T., & Protzer, U. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2017.03.019 · Cited by 27
Potential capacity of interferon-α to eliminate covalently closed circular DNA (cccDNA) in hepatocytes infected with hepatitis B virus
Wang, G., Guan, J., Khan, N. U., Li, G., Shao, J., Zhou, Q., Xu, L., Huang, C., Deng, J., Zhu, H., et al. (2021) · Gut Pathogens · doi:10.1186/s13099-021-00421-9 · Cited by 27
Class A capsid assembly modulator RG7907 clears HBV-infected hepatocytes through core-dependent hepatocyte death and proliferation
Kum, D. B., Vanrusselt, H., Sanchez, A. A., Taverniti, V., Verrier, E. R., Baumert, T. F., Liu, C., Deval, J., Corthout, N., Munck, S., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000428 · Cited by 27
Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection
Güner, R., Karahocagil, M. K., Büyükberber, M., Kandemir, Ö., Ural, O., Usluer, G., İnan, D., Köksal, İ., Baykam, N. N., Hızel, K., et al. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32834ba13a · Cited by 27
Molecular Virology of Hepatitis B Virus and Targets for Antiviral Intervention
Glebe, D., & König, A. (2014) · Intervirology · doi:10.1159/000360946 · Cited by 27
Occult hepatitis B virus infection in Egypt
Elbahrawy, A. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i12.1671 · Cited by 27
MicroRNAs as Important Players in Host-hepatitis B Virus Interactions
Kitab, B., Alj, H. S., Ezzikouri, S., & Benjelloun, S. (2015) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2015.00002 · Cited by 27
Emerging pipeline drugs for hepatitis B infection
Cox, N. R., & Tillmann, H. L. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.646260 · Cited by 26
Theories about evolutionary origins of human hepatitis B virus in primates and humans
Souza, B. F. D. C. D., Drexler, J. F., de Lima, R. S., do Rosário, M. D. O. H. V., & Netto, E. M. (2014) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2013.12.006 · Cited by 26
In vivo models of hepatitis B and C virus infection
Winer, B. Y., Ding, Q., Gaska, J. M., & Ploß, A. (2016) · FEBS Letters · doi:10.1002/1873-3468.12157 · Cited by 26
HBV Core Protein Is in Flux between Cytoplasmic, Nuclear, and Nucleolar Compartments
Nair, S., & Zlotnick, A. (2021) · mBio · doi:10.1128/mbio.03514-20 · Cited by 26
Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure
Chang, M., & Liaw, Y. (2023) · Drugs · doi:10.1007/s40265-023-01843-2 · Cited by 26
Antiviral strategies to eliminate hepatitis B virus covalently closed circular DNA (cccDNA)
Revill, P. A., & LOCARNINI, S. A. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.08.015 · Cited by 26
Current landscape and future prospects of antiviral drugs derived from microbial products
Takizawa, N., & Yamasaki, M. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2017.115 · Cited by 26
The potential of HBV cure: an overview of CRISPR-mediated HBV gene disruption
Yao, Z. Q., Schank, M., Zhao, J., Gazzar, M. E., Wang, L., Zhang, Y., Hill, A. C., Banik, P., Pyburn, J. S., & Moorman, J. P. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1467449 · Cited by 28
Clinical evaluation of hepatitis B core-related antigen in chronic hepatitis B and hepatocellular carcinoma patients
Chen, S., Jia, J., Gao, Y., Li, H., Fang, M., Feng, H., Guan, W., Ji, J., Gao, Z., & Gao, C. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.07.027 · Cited by 25
Ethanol potentiates hepatitis B virus replication through oxidative stress-dependent and -independent transcriptional activation
Min, B. Y., Kim, N. Y., Jang, E. S., Shin, C. M., Lee, S. H., Park, Y. S., Hwang, J., Jeong, S., Kim, N., Lee, D. H., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.081 · Cited by 25
Hepatitis B Virology for Clinicians
Doo, E. C., & Ghany, M. G. (2010) · Clinics in Liver Disease · doi:10.1016/j.cld.2010.05.001 · Cited by 25
Effects of the Treg/Th17 cell balance and their associated cytokines in patients with hepatitis B infection
CHEN, Y., Fang, J., Chen, X., Pan, C., Liu, X., & Liu, J. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.2104 · Cited by 25
Analysis of intrahepatic total HBV DNA, cccDNA and serum HBsAg level in Chronic Hepatitis B patients with undetectable serum HBV DNA during oral antiviral therapy
Li, J., Sun, X., Fang, J., Wang, C., Han, G., & Ren, W. (2017) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2017.03.004 · Cited by 25
The role of enhancer of zeste homolog 2: From viral epigenetics to the carcinogenesis of hepatocellular carcinoma
Sanna, L., Marchesi, I., Melone, M. A. B., & Bagella, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26545 · Cited by 26
Paradoxical Roles of Oxidative Stress Response in the Digestive System before and after Carcinogenesis
Takaki, A., Kawano, S., Uchida, D., Takahara, M., Hiraoka, S., & Okada, H. (2019) · Cancers · doi:10.3390/cancers11020213 · Cited by 24
Beyond Metabolism: Role of the Immune System in Hepatic Toxicity
Hastings, K. L., Green, M. D., Gao, B., Ganey, P. E., Roth, R. A., & Burleson, G. R. (2020) · International Journal of Toxicology · doi:10.1177/1091581819898399 · Cited by 25
Targeting Viral cccDNA for Cure of Chronic Hepatitis B
Ligat, G., Goto, K., Verrier, E. R., & Baumert, T. F. (2020) · Current Hepatology Reports · doi:10.1007/s11901-020-00534-w · Cited by 29
The Natural Course of Chronic Hepatitis B Virus Infection and Its Management
Hadziyannis, S. J., Vassilopoulos, D., & Hadziyannis, E. S. (2013) · Advances in pharmacology · doi:10.1016/b978-0-12-405880-4.00007-x · Cited by 24
Occult hepatitis B virus infection: A complex entity with relevant clinical implications
Larrubia, J. R. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i12.1529 · Cited by 24
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
Ahmed, M., Wang, F., Levin, A., Le, C., Eltayebi, Y., Houghton, M., Tyrrell, D. L., & Barakat, K. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.01.008 · Cited by 23
Animal models of HBV infection
Dandri, M., & Petersen, J. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.04.014 · Cited by 24
Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease
Nevola, R., Rinaldi, L., Giordano, M., Marrone, A., & Adinolfi, L. (2018) · Hepatoma Research · doi:10.20517/2394-5079.2018.38 · Cited by 25
HBV cccDNA─A Culprit and Stumbling Block for the Hepatitis B Virus Infection: Its Presence in Hepatocytes Perplexed the Possible Mission for a Functional Cure
Bhat, S. A., & Kazim, S. N. (2022) · ACS Omega · doi:10.1021/acsomega.2c02216 · Cited by 24
The Complex Role of HBeAg and Its Precursors in the Pathway to Hepatocellular Carcinoma
Padarath, K., Deroubaix, A., & Kramvis, A. (2023) · Viruses · doi:10.3390/v15040857 · Cited by 29
G-quadruplexes control hepatitis B virus replication by promoting cccDNA transcription and phase separation in hepatocytes
Giraud, G., Rodà, M., Huchon, P., Michelet, M., Maadadi, S., Jutzi, D., Montserret, R., Ruepp, M., Parent, R., Combet, C., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad1200 · Cited by 23
Therapy of Occult Hepatitis B Virus Infection and Prevention of Reactivation
Raimondo, G., Filomia, R., & Maimone, S. (2014) · Intervirology · doi:10.1159/000360943 · Cited by 23
The Hepatitis B Virus X Protein Inhibits Thymine DNA Glycosylase Initiated Base Excision Repair
van de Klundert, M. A. A., van Hemert, F. J., Zaaijer, H. L., & Kootstra, N. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048940 · Cited by 23
Evans Blue Inhibits HBV Replication Through a Dual Antiviral Mechanism by Targeting Virus Binding and Capsid Assembly
Xiao, Y., Liu, C., Tang, W., Zhang, H., & Chen, X. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02638 · Cited by 23
SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope
Liu, Y., Wang, H., Zhang, J., Yang, J., Bai, L., Zheng, B., Zheng, T., Wang, Y., Li, J., & Zhang, W. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00697 · Cited by 23
Mouse Models of Hepatitis B Virus Infection Comprising Host-Virus Immunologic Interactions
Inuzuka, T., Takahashi, K., Chiba, T., & Marusawa, H. (2014) · Pathogens · doi:10.3390/pathogens3020377 · Cited by 22
Genetic insights on host and hepatitis B virus in liver diseases
Tong, H. V., Bock, C. –., & Velavan, T. P. (2014) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2014.06.001 · Cited by 23
Anti-rheumatic drug-induced hepatitis B virus reactivation and preventive strategies for hepatocellular carcinoma
Zhou, Q., Zhang, Q., Wang, K., Huang, T. H., Deng, S., Wang, Y., & Cheng, C. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106181 · Cited by 22
Sequences in the terminal protein and reverse transcriptase domains of the hepatitis B virus polymerase contribute to RNA binding and encapsidation
Cao, F., Jones, S., Li, W., Cheng, X., Hu, Y., Hu, J., & Tavis, J. E. (2014) · Journal of Viral Hepatitis · doi:10.1111/jvh.12225 · Cited by 22
Recommendations for the treatment of hepatitis B in 2017
Flisiak, R., Halota, W., Jaroszewicz, J., Juszczyk, J., Małkowski, P., Pawłowska, M., Piekarska, A., Simon, K. A., Tomasiewicz, K., & Wawrzynowicz‐Syczewska, M. (2017) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2017.67626 · Cited by 22
Serum hepatitis B surface antigen correlates with tissue covalently closed circular DNA in patients with hepatitis B‐associated hepatocellular carcinoma
Wang, Q., Luan, W., Warren, L., Fiel, M. I., Blank, S., Kadri, H., Tuvin, D. M., & Hiotis, S. P. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24326 · Cited by 22
HBsAg blocks TYPE I IFN induced up-regulation of A3G through inhibition of STAT3
Xu, F., Song, H., Li, N., & Tan, G. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.03.082 · Cited by 23
Epigenetic regulation and its therapeutic potential in hepatitis B virus covalently closed circular DNA
Ren, J., Cheng, S., Ren, F., Gu, H., Wu, D., Yao, X., Tan, M., Huang, A., & Chen, J. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101215 · Cited by 21
Hepatitis B Virus RNA Profiles in Liver Biopsies by Digital Polymerase Chain Reaction
Prakash, K., Larsson, S. B., Rydell, G. E., Andersson, M., Ringlander, J., Norkrans, G., Norder, H., & Lindh, M. (2020) · Hepatology Communications · doi:10.1002/hep4.1507 · Cited by 21
Characterization of a KDM5 small molecule inhibitor with antiviral activity against hepatitis B virus
Gilmore, S. A., Tam, D., Cheung, T. L., Snyder, C. A., Farand, J., Dick, R. A., Matles, M., Feng, J. Y., Ramírez, R., Li, L., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271145 · Cited by 21
Quantitative intrahepatic HBV cccDNA correlates with histological liver inflammation in chronic hepatitis B virus infection
Liang, L.-B., Zhu, X., Yan, L.-B., Du, L., Liu, C., Liao, J., & Tang, H. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.09.022 · Cited by 21
SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B
Hoan, N. X., Tong, H. V., Giang, D. P., Cuong, B. K., Toàn, N. L., Wedemeyer, H. H., Bock, C. –., Kremsner, P. G., Song, L. H., & Velavan, T. P. (2017) · Oncotarget · doi:10.18632/oncotarget.15083 · Cited by 23
Subversion of cellular autophagy during virus infection: Insights from hepatitis B and hepatitis C viruses
Khan, M. A., Imam, H., & Siddiqui, A. (2018) · Liver Research · doi:10.1016/j.livres.2018.09.002 · Cited by 21
In Vitro Systems for Studying Different Genotypes/Sub-Genotypes of Hepatitis B Virus: Strengths and Limitations
Kinge, C. W., Bhoola, N. H., & Kramvis, A. (2020) · Viruses · doi:10.3390/v12030353 · Cited by 21
The CCCTC ‐binding factor CTCF represses hepatitis B virus enhancer I and regulates viral transcription
D’Arienzo, V., Ferguson, J., Giraud, G., Chapus, F., Harris, J. M., Wing, P. A. C., Claydon, A., Begum, S., Zhuang, X., Balfe, P., et al. (2020) · Cellular Microbiology · doi:10.1111/cmi.13274 · Cited by 21
Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach
Singh, P., Kairuz, D., Arbuthnot, P. B., & Bloom, K. M. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i23.3182 · Cited by 19
Approaches to quantifying hepatitis B virus covalently closed circular DNA
Zhang, H., & Tu, T. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2021.0283 · Cited by 20
PRKDC promotes hepatitis B virus transcription through enhancing the binding of RNA Pol II to cccDNA
Fan, Y., Liang, Y., Liu, Y., & Fan, H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04852-3 · Cited by 20
The role of HBV cccDNA in occult hepatitis B virus infection
He, P., Zhang, P., Fang, Y., Han, N., Yang, W., Xia, Z., Yi, Z., Zhang, Z., & Shen, J. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04660-z · Cited by 20
Impact of Intrahepatic Hepatitis B DNA and Covalently Closed Circular DNA on Survival After Hepatectomy in HBV-Associated Hepatocellular Carcinoma Patients
Wang, Q., Fiel, M. I., Luan, W., Blank, S., Kadri, H., Kim, K. W., & Hiotis, S. P. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3046-y · Cited by 20
New insights into hepatitis B virus biology and implications for novel antiviral strategies
Chen, J., Wu, M., Liu, K., Zhang, W., Li, Y., Zhou, X., Bai, L., & Yuan, Z. (2015) · National Science Review · doi:10.1093/nsr/nwv044 · Cited by 20
α-Fetoprotein level-dependent early hepatitis B surface antigen decline during entecavir therapy in chronic hepatitis B with hepatitis flare
Jeng, W., Chen, Y., Chang, M., & Liaw, Y. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw019 · Cited by 19
The N6-Methyladenosine Modification and Its Role in mRNA Metabolism and Gastrointestinal Tract Disease
Cai, T., Atteh, L. L., Zhang, X., Huang, C., Bai, M., Ma, H., Zhang, C., Fu, W., Gao, L., Lin, Y., et al. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.819335 · Cited by 20
Role of epigenetic modification in interferon treatment of hepatitis B virus infection
Yang, Z., Sun, B., Xiang, J., Wu, H., Kan, S., Hao, M., Chang, L., Liu, H., Wang, D., & Liu, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1018053 · Cited by 19
Decoding the multifaceted interventions between human sirtuin 2 and dynamic hepatitis B viral proteins to confirm their roles in HBV replication
Piracha, Z. Z., Saeed, U., Piracha, I. E., Noor, S., & Noor, E. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1234903 · Cited by 19
Advanced siRNA delivery in combating hepatitis B virus: mechanistic insights and recent updates
Nguyen, L., Nguyen, T. T., Kim, J., & Jeong, J. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-03004-3 · Cited by 24
Prediction of occult hepatitis B virus infection in liver transplant donors through hepatitis B virus blood markers
Tandoi, F., Caviglia, G. P., Pittaluga, F., Abate, M. L., Smedile, A., Romagnoli, R., & Salizzoni, M. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.07.172 · Cited by 19
Hepatitis B virus X protein modulates remodelling of minichromosomes related to hepatitis B virus replication in HepG2 cells
LUO, L., CHEN, S., GONG, Q., Luo, N., Yu, L., Guo, J., & He, S. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1165 · Cited by 19
CRISPR/Cas9-based tools for targeted genome editing and replication control of HBV
Peng, C., Lu, M., & Yang, D. (2015) · Virologica Sinica · doi:10.1007/s12250-015-3660-x · Cited by 19
Great and rapid HB sAg decline in patients with on‐treatment hepatitis flare in early phase of potent antiviral therapy
Jeng, W., Chen, Y., & Liaw, Y. (2017) · Journal of Viral Hepatitis · doi:10.1111/jvh.12833 · Cited by 19
Histone deacetylases and acetylated histone H3 are involved in the process of hepatitis B virus DNA replication
Zhang, D., Wang, Y., Zhang, H., Jiao, F., Zhang, W., Wang, L.-W., Zhang, H., & Gong, Z. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.010 · Cited by 20
Intracellular-delivery of a single-chain antibody against hepatitis B core protein via cell-penetrating peptide inhibits hepatitis B virus replication in vitro
Xun, Y., PAN, Q., Tang, Z., Chen, X., Yu, Y., XI, M., & Zang, G. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1210 · Cited by 19
Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable
Kefalakes, H., Jochum, C., Hilgard, G., Kahraman, A., Bohrer, A., Hindy, N. E., Heinemann, F. M., Verheyen, J., Gerken, G., Roggendorf, M., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.030 · Cited by 19
Modeling the effects of covalently closed circular DNA and dendritic cells in chronic HBV infection
Li, Q., Lu, F., Deng, G., & Wang, K. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.04.037 · Cited by 19
Optimal therapy for chronic hepatitis B: hepatitis B virus combination therapy?
Petersen, J., & Dandri, M. (2014) · Liver International · doi:10.1111/liv.12720 · Cited by 18
High Incidence of Lamivudine-Resistance-Associated Vaccine-Escape HBV Mutants among HIV-Coinfected Patients on Prolonged Antiretroviral Therapy
Pal, A., Sarkar, N., Saha, D., Guha, S. K., Saha, B., Chakrabarti, S., & Chakravarty, R. (2014) · Antiviral Therapy · doi:10.3851/imp2942 · Cited by 18
Chromosome Remodeling Related to Hepatitis B Virus Replication in HepG2 Cells
Gong, Q., Chen, S., Guo, J., Sun, H., Zheng, G., Liu, Q., Ren, H., & He, S. (2011) · DNA and Cell Biology · doi:10.1089/dna.2010.1172 · Cited by 18
Hepatitis B Virus Protein X Induces Degradation of Talin-1
van de Klundert, M. A. A., van den Biggelaar, M., Kootstra, N. A., & Zaaijer, H. L. (2016) · Viruses · doi:10.3390/v8100281 · Cited by 20
Reactivation of Occult Hepatitis B Virus Infection 27 Months after the End of Chemotherapy Including Rituximab for Malignant Lymphoma
Muraishi, J., Shibata, M., Honma, Y., Hiura, M., Abe, S., & Harada, M. (2017) · Internal Medicine · doi:10.2169/internalmedicine.56.8233 · Cited by 18
Improved Specificity and Safety of Anti-Hepatitis B Virus TALENs Using Obligate Heterodimeric FokI Nuclease Domains
Smith, T. S., Singh, P., Chmielewski, K. O., Bloom, K. M., Cathomen, T., Arbuthnot, P. B., & Ely, A. (2021) · Viruses · doi:10.3390/v13071344 · Cited by 18
Modulation of gene expression by YTH domain family (YTHDF) proteins in human physiology and pathology
Kisan, A., & Chhabra, R. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30907 · Cited by 17
A T7 Endonuclease I Assay to Detect Talen-Mediated Targeted Mutation of HBV cccDNA
Bloom, K. M., Ely, A., & Arbuthnot, P. B. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6700-1_8 · Cited by 17
Flavocoxid exerts a potent antiviral effect against hepatitis B virus
Pollicino, T., Musolino, C., Irrera, N., Bitto, A., Lombardo, D., Timmoneri, M., Minutoli, L., Raimondo, G., Squadrito, G., Squadrito, F., et al. (2017) · Inflammation Research · doi:10.1007/s00011-017-1099-2 · Cited by 17
Development of Magnetic Capture Hybridization and Quantitative Polymerase Chain Reaction for Hepatitis B Virus Covalently Closed Circular DNA
Guo, Y., Sheng, S., Nie, B., & Tu, Z. (2015) · Hepatitis Monthly · doi:10.5812/hepatmon.23729 · Cited by 16
Circulating FoxP3+ Regulatory T and Interleukin17-Producing Th17 Cells Actively Influence HBV Clearance in De Novo Hepatitis B Virus Infected Patients after Orthotopic Liver Transplantation
Gao, Y., Zhang, M., Li, J., Yang, M., Liu, Y., Guo, X., Li, H., Liu, Z., & Zhao, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137881 · Cited by 16
Retracted
A PCR assay to quantify patterns of HBV transcription
D’Arienzo, V., Magri, A., Harris, J. M., Wing, P. A. C., Ko, C., Rubio, C. O., Revill, P. A., Protzer, U., Balfe, P., & McKeating, J. A. (2019) · Journal of General Virology · doi:10.1099/jgv.0.001373 · Cited by 16
Epigenetic regulation of covalently closed circular DNA minichromosome in hepatitis B virus infection
Wang, Z., Wang, W., & Wang, L. (2020) · Biophysics Reports · doi:10.1007/s41048-020-00112-z · Cited by 16
Type-III interferon stimulated gene TRIM31 mutation in an HBV patient blocks its ability in promoting HBx degradation
Xu, F., Song, H., Xiao, Q., Wei, Q., Pang, X., Gao, Y., & Tan, G. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198650 · Cited by 16
An Ideal Hallmark Closest to Complete Cure of Chronic Hepatitis B Patients: High-sensitivity Quantitative HBsAg Loss
Wang, Z., Zheng, J.-R., Yang, R., Huang, L.-X., Chen, H., & Feng, B. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00289 · Cited by 16
The “Trojan horse” model-delivery of anti-HBV small interfering RNAs by a recombinant HBV vector
Shlomai, A., Lubelsky, Y., Har‐Noy, O., & Shaul, Y. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.016 · Cited by 16

Authors: Levrero, M., Pollicino, T., Petersen, J., Belloni, L., Raimondo, G., & Dandri, M.
Affiliations: Policlinico Umberto I (IT)
University of Messina (IT)
Sapienza University of Rome (IT)
University Medical Center Hamburg-Eppendorf (DE)
Corresponding author: Levrero, Massimo
ORCID: Levrero, Massimo
Pollicino, Teresa
Raimondo, Giovanni
Dandri, Maura
Venue: Journal of Hepatology
Publisher: Elsevier BV
Published: 2009-09
Volume: 51
Issue: 3
Pages: 581-592
ISSN: 0168-8278 (ISSN-L)
DOI: 10.1016/j.jhep.2009.05.022
OpenAlex: W2003692477
Cited by: 552
References: 90
Citations by year: 2026: 14 · 2025: 19 · 2024: 23 · 2023: 19 · 2022: 28 · 2021: 30 · 2020: 29 · 2019: 38 · 2018: 40 · 2017: 45 · 2016: 48 · 2015: 59 · 2014: 53 · 2013: 31 · 2012: 29
FWCI: 3.10
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 1414 d)
Locations: Journal of Hepatology (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
INFM-OAR (INFN Catania) (submittedVersion, cc-by-nc-nd)
Funders: Deutsche Forschungsgemeinschaft
Ministero dell’Istruzione, dell’Università e della Ricerca
Associazione Italiana per la Ricerca sul Cancro
Topics: Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
Health Sciences › Medicine › Hepatology › Hepatitis C virus research
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords: hepatitis B virus, covalently closed circular DNA, chronic hepatitis B, viral persistence, viral transcription, epigenetic regulation, histone proteins, non-histone proteins
MeSH terms: Antiviral Agents, DNA, Circular, DNA, Viral, Hepatitis B, Hepatitis B virus, Humans, Virus Replication, Epigenesis, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Control of cccDNA function in hepatitis B virus infection

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks